image
SELLAS Life Sciences Group, Inc. SLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.32
3.94 %
$ 84.9 M
Market Cap
-1.47
P/E
BALANCE SHEET
6.22 M ASSETS
-70.31%
Growth Rates
1Year -70.31%
3Years -48.69%
5Years -18.14%
7Years -28.61%
10Years -23.28%
14.2 M LIABILITIES
-11.79%
Growth Rates
1Year -11.79%
3Years -7.76%
5Years 4.00%
7Years -12.84%
10Years -16.10%
-7.98 M EQUITY
-164.42%
Growth Rates
1Year -164.42%
3Years -8.73%
5Years -20.31%
7Years -3.57%
10Years -8.94%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition SELLAS Life Sciences Group, Inc.
image
Current Assets 3.17 M
Cash & Short-Term Investments 2.53 M
Receivables 0
Other Current Assets 642 K
Non-Current Assets 3.05 M
Long-Term Investments -100 K
PP&E 858 K
Other Non-Current Assets 2.29 M
Current Liabilities 13.7 M
Accounts Payable 5.64 M
Short-Term Debt 446 K
Other Current Liabilities 7.65 M
Non-Current Liabilities 460 K
Long-Term Debt 460 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006
ASSETS
Cash & Cash Equivalents 2.5 17.1 21.4 35.3 7.3 5.3 2.3 18.1 29.7 23.6 47.8 32.8 11.4 6.9 5.7 9.9 1.8 2 K
Short Term Investments 100 K 0 0 0 0 0 0 0 0 0 0 2.7 0 0 0 0 10.0 0
Receivables 0 0 0 0 0.3 0 0 0 0 1.8 3.7 0 0 0 0 0 0 0
Inventory 0 0 0 0.5 0.6 0 0 0 (19.5) 0.7 0.4 0 0 0 0 0 0 0
Other Current Assets 0.6 0.6 1.7 1.6 0.7 0.5 10.8 0.4 23.9 2.9 1.6 0.6 0.4 0.1 0.1 73 K 22 K 0
Total Current Assets 3.2 17.8 23.0 36.9 8.2 5.8 13.1 37.5 53.6 29.0 53.5 36.1 11.8 7.0 5.8 9.9 11.7 2 K
PP&E 0.9 0.9 0.7 0.9 0.2 0 0 0.2 0.3 0.6 0.7 29 K 0.4 0.4 0.4 0.4 0.3 0
Intangible Assets 0 0 0 5.7 5.7 8.5 17.6 22.1 22.1 44.8 27.8 12.9 12.9 0 0 0 0 0
Goodwill 1.9 1.9 1.9 1.9 1.9 1.9 1.9 5.9 5.9 6.1 5.9 5.9 5.9 0 0 0 0 0
Long Term Investments (0.1) (0.2) (0.2) (1.1) 0 0 0 0 0 0 0 74 K 3 K 0 0 0 0 0
Other Long Term Assets 0.4 0.4 0.6 0.6 0.5 (0.8) 0.9 96 K 0.2 87 K 0.1 74 K 13.3 16 K 16 K 16 K 66 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 6.2 20.9 26.3 46.0 16.6 16.9 33.5 65.8 82.1 80.5 88.0 55.0 31.0 7.5 6.3 10.4 12.1 2 K
LIABILITIES
Accounts Payable 5.6 3.4 2.1 4.7 3.9 3.8 11.7 0 1.6 2.3 2.7 2.0 2.2 0.7 0.6 0.4 55 K 0
Short Term Debt 0.4 0.7 0.4 0.3 0.4 0 8.4 1.7 4.7 3.9 2.2 12 K 0.5 0.1 0.1 34 K 0 0
Other Current Liabilities 7.7 11.4 2.4 1.7 1.0 2.2 4.1 4.0 50.7 21.1 57.6 13.0 7.7 4.2 4.7 1.0 1.2 0
Total Current Liabilities 13.7 15.5 5.0 12.3 5.3 6.0 24.6 30.4 57.1 27.2 62.4 15.9 11.2 5.0 5.5 1.4 1.3 0
Long Term Debt 0.5 0.6 0.6 0.8 0 0 2.6 5.7 0 4.5 7.8 51 K 32 K 20 K 36 K 4 K 0 0
Deferred Tax Income 0 0.2 0.2 0.2 0.3 0.4 1.7 5.7 5.4 5.1 5.1 5.1 5.1 0 0 0 0 0
Other Liabilities 0 4 K 0.3 4.7 5.0 5.3 2.6 (5.7) 6.1 6.7 6.8 6.2 4.6 0 0 0 0 0
Total Liabilities 14.2 16.1 5.9 18.1 10.5 11.7 31.5 37.2 68.6 43.4 82.1 27.2 20.9 5.0 5.5 1.4 1.3 0
EQUITY
Common Stock 3 K 2 K 2 K 1 K 5 K 2 K 1 K 15 K 15 K 12 K 10 K 8 K 5 K 2 K 2 K 1 K 1 K 0
Retained Earnings (217.2) (179.9) (138.6) (117.9) (101.1) (81.9) (54.2) (302.9) (279.4) (215.5) (178.9) (102.2) (67.2) (55.7) (43.8) (25.4) (11.0) 0
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 0 0 1.6 (0.7) (0.5) (0.3) (0.2) 0 0
Total Equity (8.0) 4.9 20.3 28.0 6.1 5.2 2.1 28.7 13.5 37.1 5.9 27.8 10.1 2.4 0.7 9.0 10.8 2 K
Total Liabilities and Equity 6.2 20.9 26.3 46.0 16.6 16.9 33.5 65.8 82.1 80.5 88.0 55.0 31.0 7.5 6.3 10.4 12.1 2 K
SHARES OUTSTANDING
Common Shares Outstanding 27.8 19.4 15.5 8.0 2.6 0.3 46.8 K 6.64 K 5.17 K 3.98 K 3.01 K 2.08 K 1.21 K 612 540 458 422 420